Peishan Li Selected Research

Peishan Li Research Topics

Disease

15	Neoplasms (Cancer) 05/2024 - 01/2019
8	Breast Neoplasms (Breast Cancer) 10/2023 - 01/2019
5	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2019
3	Parkinson Disease (Parkinson's Disease) 01/2024 - 01/2022
3	Infections 05/2023 - 10/2020
3	Inflammation (Inflammations) 11/2022 - 01/2021
2	Acute Lung Injury 01/2024 - 10/2023
2	Hypoxia (Hypoxemia) 10/2023 - 03/2019
2	COVID-19 05/2023 - 01/2022
2	Septic Shock (Toxic Shock Syndrome) 01/2023 - 01/2021
2	Insulin Resistance 01/2022 - 01/2017
2	Obesity 11/2019 - 01/2017
1	Fatigue 05/2024
1	Liver Diseases (Liver Disease) 03/2024
1	Hepatocellular Carcinoma (Hepatoma) 03/2024
1	Wounds and Injuries (Trauma) 01/2024
1	Hyperuricemia 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Gout 01/2023
1	Peritonitis 01/2023
1	Disease Susceptibility (Diathesis) 01/2023
1	Vitiligo 12/2022
1	Fibrosis (Cirrhosis) 11/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2022
1	Nasal Polyps (Nasal Polyp) 11/2022
1	Rhinosinusitis 11/2022
1	Body Weight (Weight, Body) 01/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Acidosis 01/2021
1	Communicable Diseases (Infectious Diseases) 11/2020
1	Atherosclerosis 11/2020
1	Acne Vulgaris 01/2020
1	Metabolic Diseases (Metabolic Disease) 11/2019

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 01/2024 - 01/2022
3	Therapeutic UsesIBA 01/2024 - 02/2019
3	LipopolysaccharidesIBA 10/2023 - 01/2021
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2023 - 01/2019
3	Oxygen (Dioxygen)IBA 10/2023 - 01/2019
2	Imiquimod (Aldara)FDA LinkGeneric 04/2024 - 11/2022
2	LipidsIBA 01/2024 - 11/2020
2	Photosensitizing Agents (Photosensitizers)IBA 10/2023 - 02/2019
2	Hyaluronic Acid (Hyaluronan)IBA 10/2023 - 02/2019
2	ErbB Receptors (EGF Receptor)IBA 10/2023 - 01/2019
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2023 - 01/2022
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 11/2022
2	Proteins (Proteins, Gene)FDA Link 05/2022 - 10/2020
2	AntigensIBA 10/2020 - 01/2019
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2019 - 01/2017
2	GoldIBA 03/2019 - 02/2019
1	Hormones (Hormone)IBA 05/2024
1	Carbon Tetrachloride (Tetrachloromethane)IBA 03/2024
1	IronIBA 01/2024
1	PeroxidesIBA 01/2024
1	Protein Isoforms (Isoforms)IBA 11/2023
1	perfluorotributylamine (FC 43)IBA 10/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023
1	Liposomes (Liposome)IBA 10/2023
1	Succinic Acid (Succinate)IBA 10/2023
1	ChemokinesIBA 05/2023
1	InterleukinsIBA 05/2023
1	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 01/2023
1	purineIBA 01/2023
1	Uric Acid (Urate)IBA 01/2023
1	Ointments (Pastes)IBA 12/2022
1	Tacrolimus (Prograf)FDA LinkGeneric 12/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 11/2022
1	Estrogen ReceptorsIBA 09/2022
1	CCCTC-Binding FactorIBA 05/2022
1	Pramipexole (Mirapex)FDA LinkGeneric 01/2022
1	CeramidesIBA 01/2022
1	VaccinesIBA 01/2022
1	Poly I-CIBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	AntioxidantsIBA 01/2021
1	Viral AntigensIBA 10/2020
1	RNA (Ribonucleic Acid)IBA 10/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020
1	Isotretinoin (Accutane)FDA LinkGeneric 01/2020
1	RetinoidsIBA 01/2020
1	IonsIBA 03/2019
1	tetraphenylporphine sulfonate (TPPS)IBA 02/2019
1	Glutathione (Reduced Glutathione)IBA 02/2019
1	phytochlorinIBA 02/2019
1	nutlin 3IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019

Therapy/Procedure

13	Therapeutics 05/2024 - 01/2019
2	Photochemotherapy (Photodynamic Therapy) 10/2023 - 02/2019
2	Photothermal Therapy 03/2019 - 01/2019
1	Qigong (Qi Gong) 05/2024
1	Tai Ji (Tai Chi Chuan) 05/2024
1	Immunotherapy 04/2024
1	Hepatectomy 03/2024
1	Drug Therapy (Chemotherapy) 10/2023
1	Aftercare (After-Treatment) 11/2022
1	Hysterectomy 01/2022
1	Radiotherapy 03/2019
1	Precision Medicine 02/2019
1	Quantum Dots (Quantum Dot) 02/2019